Skip to main content

Find Clinical Trials

Home
Conditions
Pneumococcal Infections

Clinical trial condition

Pneumococcal Infections

Explore clinical trials studying Pneumococcal Infections. Study availability and eligibility vary by location and protocol.

118 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Pneumococcal Infections trial results

Completed

Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)

NCT02547649

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)

NCT02531373

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: Not specified

View Trial Details

Completed

Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life

NCT00625677

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations: Health Protection Agency Gloucester, United Kingdom

Health Protection Agency London, United Kingdom

View Trial Details

Completed

Immunogenicity of PCV-7 Vaccine in VLBW Infants

NCT00273325

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Stanford University Palo Alto, California, United States

University of Miami Miami, Florida, United States

Emory University Atlanta, Georgia, United States

View Trial Details

Completed

Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001)

NCT01215175

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: Not specified

View Trial Details

Completed

The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)

NCT01513551

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: Not specified

View Trial Details

Completed

A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years

NCT02955160

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: New Haven Clinical Research Unit New Haven, Connecticut, United States

View Trial Details

Completed

Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine

NCT03552445

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae

NCT02116998

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations: Royal Liverpool University Hospital, Liverpool School of Tropical Medicine Liverpool, United Kingdom

View Trial Details

Completed

Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants

NCT01446926

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +8 more
Locations: Dhaka, Bangladesh

View Trial Details